Literature DB >> 11564712

Experimental IGF-I receptor deficiency generates a sexually dimorphic pattern of organ-specific growth deficits in mice, affecting fat tissue in particular.

M Holzenberger1, G Hamard, R Zaoui, P Leneuve, B Ducos, C Beccavin, L Périn, Y Le Bouc.   

Abstract

Reduced IGF type I receptor levels diminish postnatal growth rate and adult body weight in mice. Here, we studied the impact of experimental IGF receptor deficiency on tissue-specific growth by Cre-lox-mediated dosage of a floxed IGF-IR gene. We generated mice with a wide spectrum of receptor deficiency (5-82%), and separated them into two groups with either strong (> or =50%) IGF-IR deficiency (XS mice) or moderate deficiency (<50%, M mice). The growth of XS mice was significantly retarded from 3 wk after birth onward, with respect to M littermates. This effect was twice as strong in males as in females. Growth deficits persisted throughout adult life, and at 10-12 months, most organs and tissues showed specific weight defects. Skin, bone and connective tissue, muscle, spleen, heart, lung, and brain were the most severely affected organs in the XS males. With the exception of muscle and spleen, the same tissues were also significantly reduced in size in females, although to a lesser extent. The most severe growth defect, however, concerned adipose tissue. Fat pad size in XS males was only 29% (females, 44%) of M mice. The estimated number of adipocytes in XS male fat pads was only 21% that of M males (XS female, 27%). Lipid content per cell was significantly higher in XS adipocytes, whereas plasma glucose and insulin levels were low in XS males. Thus, IGF type I receptor deficiency produced mice with disproportionate postnatal organ growth, and these effects depended strongly on sex. A marked reduction in IGF-IR levels resulted in a major defect in adipose tissue.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11564712     DOI: 10.1210/endo.142.10.8461

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  28 in total

Review 1.  Neurodevelopmental effects of insulin-like growth factor signaling.

Authors:  John O'Kusky; Ping Ye
Journal:  Front Neuroendocrinol       Date:  2012-06-16       Impact factor: 8.606

Review 2.  The IGF-I regulatory system and its impact on skeletal and energy homeostasis.

Authors:  Masanobu Kawai; Clifford J Rosen
Journal:  J Cell Biochem       Date:  2010-09-01       Impact factor: 4.429

3.  Clinical examples of disturbed IGF signaling: intrauterine and postnatal growth retardation due to mutations of the insulin-like growth factor I receptor (IGF-IR) gene.

Authors:  W Kiess; J Kratzsch; E Keller; A Schneider; K Raile; J Klammt; B Seidel; A Garten; H Schmidt; R Pfäffle
Journal:  Rev Endocr Metab Disord       Date:  2005-08       Impact factor: 6.514

Review 4.  The role of liver-derived insulin-like growth factor-I.

Authors:  Claes Ohlsson; Subburaman Mohan; Klara Sjögren; Asa Tivesten; Jörgen Isgaard; Olle Isaksson; John-Olov Jansson; Johan Svensson
Journal:  Endocr Rev       Date:  2009-07-09       Impact factor: 19.871

5.  Administration of saccharin to neonatal mice influences body composition of adult males and reduces body weight of females.

Authors:  Sebastian D Parlee; Becky R Simon; Erica L Scheller; Emilyn U Alejandro; Brian S Learman; Venkatesh Krishnan; Ernesto Bernal-Mizrachi; Ormond A MacDougald
Journal:  Endocrinology       Date:  2014-01-23       Impact factor: 4.736

6.  CTRP12 ablation differentially affects energy expenditure, body weight, and insulin sensitivity in male and female mice.

Authors:  Stefanie Y Tan; Xia Lei; Hannah C Little; Susana Rodriguez; Dylan C Sarver; Xi Cao; G William Wong
Journal:  Am J Physiol Endocrinol Metab       Date:  2020-05-18       Impact factor: 4.310

Review 7.  A model for tissue-specific inducible insulin-like growth factor-I (IGF-I) inactivation to determine the physiological role of liver-derived IGF-I.

Authors:  Klara Sjögren; John-Olov Jansson; Olle G P Isaksson; Claes Ohlsson
Journal:  Endocrine       Date:  2002-12       Impact factor: 3.633

Review 8.  Regulation of skeletal growth and mineral acquisition by the GH/IGF-1 axis: Lessons from mouse models.

Authors:  Shoshana Yakar; Olle Isaksson
Journal:  Growth Horm IGF Res       Date:  2015-09-28       Impact factor: 2.372

9.  Insulin-like growth factor 1 receptor signaling regulates skin development and inhibits skin keratinocyte differentiation.

Authors:  Marianna Sadagurski; Shoshana Yakar; Galina Weingarten; Martin Holzenberger; Christopher J Rhodes; Dirk Breitkreutz; Derek Leroith; Efrat Wertheimer
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

Review 10.  The insulin paradox: aging, proteotoxicity and neurodegeneration.

Authors:  Ehud Cohen; Andrew Dillin
Journal:  Nat Rev Neurosci       Date:  2008-09-04       Impact factor: 34.870

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.